Evidence map›Paper›PMID 31166373›Full record

ArticleJornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia2019

Molecular profile of non-small cell lung cancer in northeastern Brazil.

Ana Claudia da Silva Mendes de Oliveira, Antonio Vinicios Alves da Silva, Marclesson Alves, Eduardo Cronemberger, Benedito Arruda Carneiro, Juliana Carneiro Melo, Francisco Martins Neto, Fabio Tavora

Abstract read
In one paragraph

Article in Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Simultaneous analysis ofTranslational lung cancer research · 2021
    Article
  8. Testing forOncoTargets and therapy · 2021
    Review
  9. The importance of molecular characterization in lung cancer.Jornal brasileiro de pneumologia : publicacao oficial da Sociedade Brasileira de Pneumologia e Tisilogia · 2019
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Ana Claudia da Silva Mendes de OliveiraPrograma de Pós-Graduação em Patologia, Universidade Federal do Ceará, Fortaleza (CE) Brasil.ORCID http://orcid.org/0000-0001-6035-8846
Antonio Vinicios Alves da SilvaLaboratório Argos, Fortaleza (CE) Brasil.ORCID http://orcid.org/0000-0002-6266-3366
Marclesson AlvesUnidade de Oncologia, Pronutrir Oncologia e Nutrição, Fortaleza (CE) Brasil.ORCID http://orcid.org/0000-0002-1662-3398
Eduardo CronembergerUnidade de Oncologia, Pronutrir Oncologia e Nutrição, Fortaleza (CE) Brasil.ORCID http://orcid.org/0000-0001-8493-7287
Benedito Arruda CarneiroLifespan Cancer Institute, Warren Alpert Medical School, Brown University, Providence (RI) USA.ORCID http://orcid.org/0000-0002-5468-1126
Juliana Carneiro MeloPrograma de Pós-Graduação em Saúde Coletiva, Universidade de Fortaleza -UNIFOR - Fortaleza (CE) Brasil.ORCID http://orcid.org/0000-0003-1734-3352
Francisco Martins NetoUnidade de Cirurgia Torácica, Hospital de Messejana Dr. Carlos Alberto Studart Gomes, Fortaleza (CE) Brasil.ORCID http://orcid.org/0000-0003-2565-365X
Fabio TavoraPrograma de Pós-Graduação em Patologia, Universidade Federal do Ceará, Fortaleza (CE) Brasil.ORCID http://orcid.org/0000-0003-2361-0613

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo investigate the histological subtypes and mutational profiles of non-small cell lung cancer in Brazil, looking for correlations among histological subtypes, expression of anaplastic lymphoma kinase (ALK), EGFR mutation status, and programmed death-ligand 1 (PD-L1) expression.

methodsWe evaluated 173 specimens obtained from patients with lung adenocarcinoma in northeastern Brazil. Expression of PD-L1 and ALK was evaluated by immunohistochemistry; EGFR mutation status was evaluated by sequencing. We categorized the histological subtypes in accordance with the International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification.

resultsThe most common histological subtypes of lung adenocarcinoma were solid predominant (in 46.8%), acinar predominant (in 37.0%), and lepidic predominant (in 9.8%). ALK expression was detected in 10.4% of the samples, and 22.0% of the tumors harbored EGFR mutations. The most common EGFR mutation was an exon 21 L858R point mutation (in 45.5%), followed by an exon 19 deletion (in 36.3%). The tumor proportion score for PD-L1 expression was ≥ 50% in 18.2% of the samples, 1-49% in 32.7%, and 0% in 49.5%. The solid predominant subtype was significantly associated with wild-type EGFR status (p = 0.047). Positivity for PD-L1 expression was not found to be significantly associated with ALK expression or EGFR mutation status.

conclusionsOur results suggest that the molecular profile of non-small cell lung cancer in northeastern Brazil differs from those of populations in other regions of the country, with ALK positivity being higher than the other biomarkers. Further studies including clinical and genetic information are required to confirm these differences, as well as studies focusing on populations living in different areas of the country.

Indexed as

AdenocarcinomaAdultAgedAged, 80 and overAnaplastic Lymphoma KinaseB7-H1 AntigenBiopsyBrazilCarcinoma, Non-Small-Cell LungFemaleGenes, erbB-1HumansImmunohistochemistryLung NeoplasmsMaleMiddle AgedAnaplastic Lymphoma KinaseB7-H1 AntigenCD274 protein, human

Identifiers

PMID31166373
PMCPMC6715033

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.